Skip to main content
SpringerLink
Log in

Keine Verbesserung des progressionsfreien Überlebens von Patienten mit lokal fortgeschrittenem NSCLC durch konsolidierende Chemotherapie nach simultaner Radiochemotherapie

Progression-free survival of patients with locally advanced NSCLC not improved by consolidation chemotherapy after concurrent chemoradiation

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L (2004) Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46:87–98

    Article  PubMed  Google Scholar 

  2. Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD (2011) Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase iii trial RTOG 9410. J Natl Cancer Inst 103:1452–1460

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat M-C, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon J-P (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer. J Clin Oncol 28:2181–2190

    Article  PubMed  Google Scholar 

  4. Belani CP, Choy H, Bonomi P, Scott C, Travis P, Haluschak J, Curran WJ (2005) combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non–small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23:5883–5891

    Article  PubMed  CAS  Google Scholar 

  5. Ahn JS, Ahn YC, Kim J-H, Lee CG, Cho EK, Lee KC, Chen M, Kim D-W, Kim H-K, Min YJ, Kang J-H, Choi J-H, Kim S-W, Zhu G, Wu Y-L, Kim SR, Lee KH, Song HS, Choi Y-L, Sun J-M, Jung S-H, Ahn M-J, Park K (2015) Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non-small-cell lung cancer: KCSG-LU05-04. J Clin Oncol 33:2660–2666

    Article  PubMed  CAS  Google Scholar 

  6. Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran WJ, Choy H (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187–199

    Article  PubMed  CAS  Google Scholar 

  7. Auperin A, Le Pechoux C, Pignon JP, Koning C, Jeremic B, Clamon G, Einhorn L, Ball D, Trovo MG, Groen HJM, Bonner JA, Le Chevalier T, Arriagada R (2006) Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 17:473–483

    Article  PubMed  CAS  Google Scholar 

  8. Pignon J-P, le Maître A, Bourhis J (V) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69:S112–S114

  9. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration (2008) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802–5812

    Article  PubMed Central  Google Scholar 

  10. Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN, Burris H, Gumerlock P, Kuebler JP, Bearden JD, Crowley J, Livingston R (2003) Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non–small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol 21:2004–2010

    Article  PubMed  CAS  Google Scholar 

  11. Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L (2008) Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non–small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755–5760

    Article  PubMed  CAS  Google Scholar 

  12. Jain AK, Hughes RS, Sandler AB, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H (2009) A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC). J Thorac Oncol 4:722–727

    Article  PubMed  Google Scholar 

  13. Lee KC, Lee SH, Lee Y, Park SH, Park J, Cho EK, Shin DB, Lee JH, Kim DY, Kim ST (2008) Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 71:187–191

    Article  PubMed  CAS  Google Scholar 

  14. Tsujino K, Kurata T, Yamamoto S, Kawaguchi T, Kubo A, Isa S, Hasegawa Y, Ou SH, Takada M, Ando M (2013) Is consolidation chemotherapy after concurrent chemo-radiotherapy beneficial for patients with locally advanced non-small-cell lung cancer? A pooled analysis of the literature. J Thorac Oncol 8:1181–1189

    Article  PubMed  CAS  Google Scholar 

  15. NSCLC Meta-analyses Collaborative Group (2010) Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375:1267–1277

    Article  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland

    Nadja Ebert &  Michael Baumann

Authors
  1. Nadja Ebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadja Ebert.

Ethics declarations

Interessenkonflikt

N. Ebert und M. Baumann geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ebert, N., Baumann, M. Keine Verbesserung des progressionsfreien Überlebens von Patienten mit lokal fortgeschrittenem NSCLC durch konsolidierende Chemotherapie nach simultaner Radiochemotherapie. Strahlenther Onkol 192, 133–135 (2016). https://doi.org/10.1007/s00066-015-0933-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-015-0933-0

Search

Navigation